The Brugada syndrome is an inherited channelopathy that alters the main transmembrane
ion currents that constitute the cardiac action potential. These changes not only modify the …

The incidence of Brugada syndrome (BS) is relatively high in Japan compared with the rest
of the world, ranging between 0.1% and 0.2% in the general population. BS in Japan, as in …

Brugada syndrome (BrS) is an inherited cardiac arrhythmia syndrome first described as a
new clinical entity in 1992. Electrocardiographically characterized by distinct coved type ST …

Background—Implantable cardioverter-defibrillator indications in Brugada syndrome remain
controversial, especially in asymptomatic patients. Previous outcome data are limited by …

Background: Implantable cardioverter-defibrillator (ICD) indications for primary prevention in
Brugada syndrome (BrS) are still debated. Objectives: The authors investigated the long …

The Brugada syndrome is an inherited disorder associated with risk of ventricular fibrillation
and sudden cardiac death in a structurally normal heart. Diagnosis is based on a …

Background. The benefit of the implantable cardioverter defibrillator in a large cohort of
patients with Brugada syndrome has not been assessed.• Methods. Of 690 patients with …

The Brugada syndrome is a congenital syndrome of sudden cardiac death first described as
a new clinical entity in 1992. Electrocardiographically characterized by a distinct coved-type …

Background: Many electrophysiologists recommend implantable cardioverter defibrillators
for patients with Brugada syndrome who are cardiac arrest survivors or presumed at high …

The Brugada syndrome is an autosomal dominant disease with incomplete penetrance that
may cause syncope and sudden cardiac death in young individuals with a normal heart. It is …